Bacteria can compete in the environment using antibacterial type VI secretion systems. A recent study reveals that the simultaneous deployment of an arsenal of different toxins promotes both synergy between those toxins and an optimized answer in the face of inconstant environments.
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A lthough discovered more recently than other protein secretion systems, the type VI secretion system (T6SS) is unexpectedly one of the most widespread among Gram-negative bacteria. Notably, it was the first secretion system discovered that injects antibacterial effectors into target bacteria 1 . The T6SS can thus confer a fitness advantage against rival bacteria in different niches -for example, both inter-and intraspecies competitiveness has been described in the environment, and in eukaryotic hosts T6SSs have been implicated in competition between commensal bacteria 2 and between pathogenic and commensal bacteria 3 . In addition, some T6SSs are specialized for disarming the eukaryotic host cell.
The opportunistic pathogen Pseudomonas aeruginosa employs three independent T6SSs as antibacterial weapons, two of which also mediate interactions with epithelial cells 4 . The H1-T6SS was the first antibacterial T6SS ever described 1 and only an antibacterial role has so far been attributed to this system. Seven H1-T6SS effectors have been found, and they disable various cellular components in target bacteria. Immunity proteins, also called antitoxins, bind to the cognate effector proteins to prevent sister cell attack and, in the case of cytoplasmic toxins, prevent self-intoxication. While a single effector protein can kill a competitor, P. aeruginosa, like many bacteria, carries an arsenal of effector proteins. However, why bacteria benefit from the delivery of multiple effectors with diverse activities into target cells, is unclear.
In a recent study in Nature Microbiology 5 , LaCourse and colleagues tackled this question and proposed two hypotheses that may not be mutually exclusive. Do environmental conditions impact effector activity and are some effectors more adapted to particular environments? Or, do the multiple effectors act synergistically? To address these, the authors developed a powerful assay, called PAEE (parallel analysis of effector efficacy), using six of the P. aeruginosa H1-T6SS effectors. In a classical competition assay, the c.f.u. of the target bacteria would be counted for each different condition (that is, wild type versus mutant, or according to various growth parameters), using many plates and large amounts of time. By contrast, PAEE is a high-throughput pooled-method based on sequencing unique barcodes introduced into a library of 21 mutants in which one or two of the six effector-immunity gene pairs have been deleted (Fig. 1) . The library was grown under a variety of environmental conditions in contact with an excess of the unbarcoded parental strain that acts as a donor for the six effectors. The authors tested whether pH, oxygen availability, temperature or salinity influenced the ability of the parental strain effectors to kill the different effectorimmunity-deficient mutants.
The PAEE assay enabled the authors to observe exciting phenotypes, including that the activities of the six effectors are conditioned by the environment. For instance, the killing activity of the effector Tse5 (whose function is unknown) increases between pH 6-8 and at higher osmolarity, but decreases at higher temperatures. Importantly, effector activity was not linked to gene regulation but rather toxins tended to be intrinsically more active in a particular environment. The authors also tested whether toxins act in synergy by studying the different effector-immunity double mutants. They observed that Tse1 (an amidase that targets the cell wall of An excess of parental P. aeruginosa (acting as a toxin donor) was mixed with a library of 21 mutants plus a parental strain that were all individually tagged with a specific barcode. The co-cultures were grown under various conditions of pH, salinity, temperature and oxygen. After incubation, susceptibility to intoxication was assessed by comparing the frequencies of each barcode associated with a given mutant (following barcode amplification and Illumina sequencing). Numbers represent the effector-immunity (tse-tsi) pair genes deleted in each mutant, and parental refers to a PAO1Δ retS strain (in which Tse1-6 effectors are produced constitutively).
competing bacteria), Tse4 (whose function was unknown) and Tse6 (a NADP + glycohydrolase that depletes NADP + levels in the target cell) act strongly in synergy with other toxins. For example, the muramidase Tse3 (which also degrades the cell wall of target bacteria) functions in synergy with Tse4 in all conditions, including at high pH where its activity in the absence of Tse4 decreases greatly. Furthermore, some synergistic pairs depend on environmental conditions; Tse4 and Tse1 were synergistic at high salinity, and Tse2 and Tse6 during anaerobiosis. These results demonstrate that effector-pair relationships can be conditional. Finally, in one case anti-synergy was observed between Tse4 and Tse5, whose cumulative activities were at or below the sum of their individual activities. Not all possible interactions were studied and, for example, the use of triple or higher order mutants might be expected to reveal synergy between groups of toxins that are not synergistic in pairs. The level of synergy between toxins is thus probably underestimated compared to the situation in vivo. Nonetheless, the arsenal of T6SS effectors acts synergistically and its activity is modulated in response to varying environmental conditions. Interestingly, PAEE revealed a key role for the poorly characterized effector Tse4 (ref. 6 ). Tse4 was found to act in synergy with Tse1, Tse3 and Tse6, three effectors that harbour distinct activities: the first two are bactericidal toxins that target peptidoglycan, whereas Tse6 is bacteriostatic by depleting NADP + in the cytoplasm. To clarify what kind of activity enables Tse4 to synergize with such distinct effectors, the authors used a series of experiments to demonstrate that Tse4 is likely to function as a novel ion-selective membrane pore. Tse4 is found in the inner membrane of P. aeruginosa and contains glycine zipper motifs that are implicated in transmembrane-domain multimerization in pore-forming proteins. The authors demonstrated that these glycine zipper motifs are required for Tse4 toxicity. By constructing a self-intoxication strain by deletion of tsi4 (the gene coding Tse4 immunity), they showed that loss of Tse4 led to the permeability of the inner membrane to ions due to an altered membrane potential (Δ Ψ ) component of the proton motive force (PMF). Membrane-disrupting activities have been previously described for T6SS effectors, such as VasX that binds phosphoinositides 7 or type VI lipase effectors 8 , but never a pore-forming activity as found for Tse4. The authors propose that the synergy between Tse4 and cell-wall-degrading effectors (Tse1 and Tse3) may rely on PMF-sensitive autolysin activation and that Tse4 could exacerbate the consequences of NADP + depletion by Tse6 through inhibiting Δ Ψ dependent transporters.
In conclusion, the work of LaCourse and colleagues establishes that the concomitant delivery of multiple toxins allows both synergy between these effectors and optimized action in a wide range of environmental conditions. Another benefit of a broad repertoire of effectors, as discussed by the authors, may be to minimize the emergence of resistance among competitors, in a scenario analogous to the use of antibiotic combination therapies to prevent drug resistance. Finally, this work raises important questions as to the extent of synergy that can occur between effectors of different species in complex environments, such as the gut and in polymicrobial infections, and about the strategies used by target bacteria to defend against these synergies. ❐ Sophie Bleves* and Benjamin Berni 
